| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | 15.2% | RBC Capital | $29 → $28 | Maintains | Outperform |
| 09/14/2023 | -1.25% | Jefferies | $23 → $24 | Maintains | Hold |
| 08/02/2023 | 19.32% | RBC Capital | $30 → $29 | Maintains | Outperform |
| 06/29/2023 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 06/09/2023 | 6.97% | Keefe, Bruyette & Woods | → $26 | Reiterates | Market Perform → Market Perform |
| 05/03/2023 | 23.43% | RBC Capital | → $30 | Reiterates | → Outperform |
| 04/12/2023 | -1.25% | Morgan Stanley | $26 → $24 | Maintains | Equal-Weight |
| 04/05/2023 | -1.25% | Piper Sandler | $28 → $24 | Maintains | Neutral |
| 02/24/2023 | 6.97% | Morgan Stanley | $25 → $26 | Maintains | Equal-Weight |
| 02/21/2023 | 2.86% | Jefferies | $23 → $25 | Maintains | Hold |
| 02/09/2023 | 15.2% | RBC Capital | $26 → $28 | Maintains | Outperform |
| 02/08/2023 | -5.37% | Piper Sandler | → $23 | Maintains | Neutral |
| 01/10/2023 | 2.86% | Morgan Stanley | $24 → $25 | Maintains | Equal-Weight |
| 11/17/2022 | -1.25% | Morgan Stanley | $23 → $24 | Maintains | Equal-Weight |
| 11/02/2022 | 6.97% | RBC Capital | $25 → $26 | Maintains | Outperform |
| 10/07/2022 | -17.71% | Piper Sandler | $19 → $20 | Maintains | Neutral |
| 09/13/2022 | 2.86% | RBC Capital | → $25 | Initiates Coverage On | → Outperform |
| 07/08/2022 | -21.83% | Piper Sandler | $22 → $19 | Maintains | Neutral |
| 07/06/2022 | -5.37% | Morgan Stanley | $27 → $23 | Maintains | Equal-Weight |
| 05/27/2022 | -9.48% | Piper Sandler | $23 → $22 | Maintains | Neutral |
| 05/03/2022 | 11.09% | Morgan Stanley | $28 → $27 | Maintains | Equal-Weight |
| 04/08/2022 | 15.2% | Morgan Stanley | $29 → $28 | Maintains | Equal-Weight |
| 01/26/2022 | 2.86% | Jefferies | → $25 | Initiates Coverage On | → Hold |
| 01/07/2022 | 15.2% | Morgan Stanley | $27 → $28 | Maintains | Equal-Weight |
| 01/05/2022 | — | Piper Sandler | Downgrades | Overweight → Neutral | |
| 09/10/2021 | 11.09% | Piper Sandler | $25 → $27 | Upgrades | Neutral → Overweight |
| 04/01/2021 | 11.09% | Morgan Stanley | $25 → $27 | Maintains | Equal-Weight |
| 03/31/2021 | 2.86% | Piper Sandler | → $25 | Downgrades | Overweight → Neutral |
| 02/25/2021 | 2.86% | Morgan Stanley | $24 → $25 | Maintains | Equal-Weight |
| 01/15/2021 | -1.25% | Morgan Stanley | $20 → $24 | Maintains | Equal-Weight |
| 11/18/2020 | -17.71% | Morgan Stanley | $19 → $20 | Maintains | Equal-Weight |
| 11/04/2020 | -9.48% | Piper Sandler | $20 → $22 | Maintains | Overweight |
| 11/03/2020 | -21.83% | Morgan Stanley | $18 → $19 | Maintains | Equal-Weight |
| 10/07/2020 | -17.71% | Piper Sandler | $19 → $20 | Maintains | Overweight |
| 10/06/2020 | -25.94% | Morgan Stanley | $17 → $18 | Maintains | Equal-Weight |
| 09/01/2020 | -21.83% | Piper Sandler | $17 → $19 | Upgrades | Neutral → Overweight |
| 08/20/2020 | -30.06% | Morgan Stanley | $16 → $17 | Maintains | Equal-Weight |
| 08/05/2020 | -34.17% | Morgan Stanley | $15 → $16 | Maintains | Equal-Weight |
| 07/06/2020 | -38.28% | Morgan Stanley | $13 → $15 | Maintains | Equal-Weight |
| 07/02/2020 | -38.28% | Piper Sandler | $14 → $15 | Maintains | Neutral |
| 06/18/2020 | -21.83% | Goldman Sachs | $17 → $19 | Upgrades | Neutral → Buy |
| 05/29/2020 | -17.71% | B. Riley Securities | $15 → $20 | Upgrades | Neutral → Buy |
| 05/20/2020 | -42.4% | Piper Sandler | → $14 | Initiates Coverage On | → Neutral |
| 04/21/2020 | -38.28% | B. Riley Securities | $18 → $15 | Maintains | Neutral |
| 03/23/2020 | -25.94% | B. Riley Securities | $20 → $18 | Maintains | Neutral |
| 03/17/2020 | -46.51% | Morgan Stanley | $19 → $13 | Maintains | Equal-Weight |
| 03/11/2020 | -17.71% | B. Riley Securities | $24 → $20 | Downgrades | Buy → Neutral |
| 03/11/2020 | -17.71% | B. Riley Securities | $24 → $20 | Downgrades | Buy → Neutral |
| 09/13/2019 | -30.06% | Citigroup | $18 → $17 | Maintains | Neutral |
What is the target price for CNO Finl Group (CNO)?
The latest price target for CNO Finl Group (NYSE: CNO) was reported by RBC Capital on November 8, 2023. The analyst firm set a price target for $28.00 expecting CNO to rise to within 12 months (a possible 15.20% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CNO Finl Group (CNO)?
The latest analyst rating for CNO Finl Group (NYSE: CNO) was provided by RBC Capital, and CNO Finl Group maintained their outperform rating.
When is the next analyst rating going to be posted or updated for CNO Finl Group (CNO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CNO Finl Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CNO Finl Group was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating CNO Finl Group (CNO) correct?
While ratings are subjective and will change, the latest CNO Finl Group (CNO) rating was a maintained with a price target of $29.00 to $28.00. The current price CNO Finl Group (CNO) is trading at is $24.31, which is out of the analyst's predicted range.